Response to case report on myocarditis and pericarditis after COVID‐19 vaccination

Response to case report on myocarditis and pericarditis after COVID‐19 vaccination

Dettagli Bibliografici
Autori principali:	Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Natura:	Articolo
Lingua:	English
Pubblicazione:	Wiley 2021-10-01
Serie:	Journal of the American College of Emergency Physicians Open
Accesso online:	https://doi.org/10.1002/emp2.12559

Documenti analoghi

Myocarditis and COVID-19 mRNA vaccination
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-08-01)

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-06-01)

Acute kidney injury after COVID-19 vaccines: correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-12-01)

Expected response to the additional fifth dose of COVID-19 vaccine
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Multiple sclerosis patients’ response to COVID-19 pandemic and vaccination: correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Myocarditis and pericarditis after vaccination for COVID‐19
di: Blake Hudson, et al.
Pubblicazione: (2021-08-01)

Addressing COVID-19 vaccine hesitancy
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-11-01)

COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-01-01)

Safety Interval From Increased Viscosity After COVID-19 Vaccination Among Persons With Cerebrovascular Problems
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2021-09-01)

COVID-19 Vaccination in Cancer Patients: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-11-01)

COVID-19 vaccine and its effect on sperm
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Correspondence on “Extreme heat and COVID-19 vaccination sites”
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2021-10-01)

COVID-19 Vaccination and Abnormal Blood Glucose Level
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Parsonage–Turner syndrome and COVID-19 vaccine: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Comment on “Knowledge, Attitude, and Acceptability of COVID-19 Vaccine”
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Abnormal thyroid function following COVID-19 vaccination
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2021-01-01)

Correspondence on “Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non‐small‐cell lung cancer patient”
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-04-01)

Concurrent administration of COVID-19 vaccine and seasonal influenza vaccine: Expected rate of adverse effect
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: Correspondence human vaccines & immunotherapeutics
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-12-01)

Attitude and perception of COVID-19 vaccines and healthcare workers: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-04-01)

Correspondence on Intention to vaccinate young children against COVID-19
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-11-01)

New COVID-19 vaccine, thiomerosol, and reversible cerebral vasoconstriction
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-01-01)

Hypoparathyroidism in a COVID-19 vaccine recipient: An issue for further research
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2024-01-01)

Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-03-01)

Willingness to pay for a COVID-19 vaccine for oneself and one's child: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Ensuring Interrater Reliability When Evaluating Voice Assistants. Comment on “Evaluating Voice Assistants’ Responses to COVID-19 Vaccination in Portuguese: Quality Assessment”
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-03-01)

COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome: Concern on antiplatelet factor 4 testing
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-12-01)

Expected Additional Protection Rate against Omicron COVID-19 Infection and Death for the Fifth Dose of COVID-19 Vaccine: An Appraisal from an Endemic Area in Indochina
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2024-01-01)

Local center of disease control communication for international response to the COVID-19: A comment
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2021-01-01)

Comment to: Post-vaccination incidence and side effects of COVID-19 in a cohort of Brazilian healthcare professionals: an internet-based survey
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-04-01)

Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Letter to the Editor in Response to the "Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm"
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-12-01)

Hemoglobinopathy and COVID-19
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2021-07-01)

Variability in case fatality rate risk due to Covid-19 and health services provider
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-07-01)

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-12-01)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2022-11-01)

Comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2023-01-01)

Underreporting of COVID-19 deaths
di: Rujittika Mungmunpuntipantip, et al.
Pubblicazione: (2021-10-01)

ECONOMIC IMPACT OF COVID-19
di: RUJITTIKA MUNGMUNPUNTIPANTIP, et al.
Pubblicazione: (2023-02-01)